Firefly Neuroscience, Inc. is collaborating with Prof. Dr. Christian Schaaf from the Institute of Human Genetics at Heidelberg University Hospital on a study investigating the neurophysiological ...
Please provide your email address to receive an email when new articles are posted on . A global clinical-stage biopharmaceutical company announced positive biomarker data from its exploratory phase 1 ...
A new artificial intelligence (AI) model may improve patient diagnosis and care among specialized epilepsy centers in underserved areas. The use of an artificial intelligence (AI) model to interpret ...
Researchers have developed a machine learning model capable of predicting whether a patient with depression will respond to ...
PURCHASE, N.Y., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (CGTX), (Nasdaq: CGTX), (the “Company” or “Cognition”) announced that Willem de ...
Please provide your email address to receive an email when new articles are posted on . The trial will include a headband device and neurobiomarker platform to conduct EEG and sleep analyses in those ...
Why Use EEG in the Critically Ill? Wilner: Thanks for joining us. I’m really glad we have this opportunity because this is a question that’s been bothering me about the application of resources. A ...
A new study from researchers at MIT's Media Lab reveals that ChatGPT may be chipping away at our cognitive abilities. The study focused on ChatGPT effects on the brain and, in particular, our ability ...
PURCHASE, N.Y., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (CGTX), (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results